Biolase (NASDAQ:BIOL): Closing price $3.37
The maker and distributor of dental lasers Biolase reported Wednesday that the FDA has approved the 940nm Diolase 10 diode soft tissue laser for use in 19 additional medical markets, including arthroscopy, ear, nose and throat; oral surgery, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery. This FDA clearance includes more than 80 different procedures.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.